BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19949067)

  • 1. Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitis.
    Nicolò C; Sali M; Di Sante G; Geloso MC; Signori E; Penitente R; Uniyal S; Rinaldi M; Ingrosso L; Fazio VM; Chan BM; Delogu G; Ria F
    J Immunol; 2010 Jan; 184(1):222-35. PubMed ID: 19949067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
    J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K; Chandler P; Altmann DM
    Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis.
    Javeri S; Rodi M; Tary-Lehmann M; Lehmann PV; Addicks K; Kuerten S
    Clin Immunol; 2010 Nov; 137(2):181-9. PubMed ID: 20797911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
    Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
    Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
    Mohindru M; Kang B; Kim BS
    J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
    Peng Y; Liu CP
    Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides.
    Whitham RH; Kotzin BL; Buenafe AC; Weinberg AD; Jones RE; Hashim GA; Hoy CM; Vandenbark AA; Offner H
    J Neurosci Res; 1993 Jun; 35(2):115-28. PubMed ID: 7686583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE.
    Xu B; Haviernik P; Wolfraim LA; Bunting KD; Scott DW
    Mol Ther; 2006 Jan; 13(1):42-8. PubMed ID: 16219491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage.
    Kuchroo VK; Sobel RA; Laning JC; Martin CA; Greenfield E; Dorf ME; Lees MB
    J Immunol; 1992 Jun; 148(12):3776-82. PubMed ID: 1376341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice.
    Massilamany C; Steffen D; Reddy J
    J Neuroimmunol; 2010 Feb; 219(1-2):17-24. PubMed ID: 20005578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of CD4 co-receptor limits spontaneous autoimmunity when high-affinity transgenic TCR specific for self-antigen is expressed on a genetically resistant background.
    Illés Z; Waldner H; Reddy J; Anderson AC; Sobel RA; Kuchroo VK
    Int Immunol; 2007 Oct; 19(10):1235-48. PubMed ID: 17804690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice.
    Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H
    J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
    J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.
    Sobel RA; Kuchroo VK
    J Immunol; 1992 Aug; 149(4):1444-51. PubMed ID: 1380045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
    Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
    J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An organic CD4 inhibitor reduces the clinical and pathological symptoms of acute experimental allergic encephalomyelitis.
    Edling AE; Choksi S; Huang Z; Korngold R
    J Autoimmun; 2002 Mar; 18(2):169-79. PubMed ID: 11908949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
    Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
    J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
    Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
    J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.